NLRP3 and myeloid sarcoma: The activation of NLRP3 inflammasome has been demonstrated to contribute to pathology in a broad spectrum of neurological diseases, such as traumatic brain injury, spinal cord injury, Alzheimer’s disease, amyotrophic lateral sclerosis, and MS [35].